Dr Catherine Han

Dr Catherine Han is a New Zealand trained Medical Oncologist with a special interest in gastro-intestinal, breast and brain cancers. She also has a great interest in cancer molecular profiling and genomics, personalised cancer treatments, and neurological complications of cancer drugs.
In 2011 she was awarded a Health Research Council of New Zealand (HRC) Clinical Research Training Fellowship. With the support of this prestigious award, she was able to pursue a PhD degree and a period of clinical research training.
She is a recipient of several prizes and scholarships. Her cancer research work on oxaliplatin-induced neurotoxicity has resulted in the overall Excellence in Health Research top award for the Auckland District Health Board for 2014, and the Fred Fastier Trust prize for the best oral research presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) 2013 annual meeting. She was also awarded a Cancer Society Research Training Scholarship and a Genesis Oncology Trust Murray Jackson Clinical Fellowship.
In 2015 she was awarded the Sir Owen Glenn Clinical Research Fellowship and works as a part-time senior clinical research fellow in the Auckland Cancer Society Research Centre where she is involved in clinical trials of new molecularly targeted anti-cancer drugs, and clinical research projects concerning cancer genomics.
More recently, she spent a year on sabbatical at Massachusetts General Hospital of Harvard Medical School, Boston, USA (July 2016 to June 2017). She focused her time there on brain cancers and gastrointestinal cancers (oesophageal, stomach, bowel and pancreatic cancers).
 

« Back